Intact fibroblast growth factor 23 in heart failure with reduced and mildly reduced ejection fraction
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
Online-Ressource, 1 online resource.
- Language
-
Englisch
- Bibliographic citation
-
Intact fibroblast growth factor 23 in heart failure with reduced and mildly reduced ejection fraction ; volume:23 ; number:1 ; day:1 ; month:9 ; year:2023 ; pages:1-8 ; date:12.2023
BMC cardiovascular disorders ; 23, Heft 1 (1.9.2023), 1-8, 12.2023
- Creator
-
Vergaro, Giuseppe
Del Franco, Annamaria
Aimo, Alberto
Gentile, Francesco
Castiglione, Vincenzo
Saponaro, Federica
Masotti, Silvia
Prontera, Concetta
Fusari, Niccolò
Emdin, Michele
Passino, Claudio
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s12872-023-03441-2
- URN
-
urn:nbn:de:101:1-2023111015244455474133
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:53 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Vergaro, Giuseppe
- Del Franco, Annamaria
- Aimo, Alberto
- Gentile, Francesco
- Castiglione, Vincenzo
- Saponaro, Federica
- Masotti, Silvia
- Prontera, Concetta
- Fusari, Niccolò
- Emdin, Michele
- Passino, Claudio
- SpringerLink (Online service)
Other Objects (12)
Real-world comparative effectiveness of ARNI versus ACEi/ARB in HF with reduced or mildly reduced ejection fraction
Predictors of mortality in heart failure patients with reduced or mildly reduced Ejection Fraction: The CASABLANCA HF Study
Association between class of foundational medication for heart failure and prognosis in heart failure with reduced/mildly reduced ejection fraction
Healthcare resource utilization and costs among patients with heart failure with preserved, mildly reduced, and reduced ejection fraction in Spain
Guideline-directed medical therapy is similarly effective in heart failure with mildly reduced ejection fraction
Semaglutide in patients with obesity and heart failure across mildly reduced or preserved ejection fraction
Guideline-directed medical therapy is similarly effective in heart failure with mildly reduced ejection fraction
Prognostic impact of prior LVEF in patients with heart failure with mildly reduced ejection fraction
Phenogrouping heart failure with preserved or mildly reduced ejection fraction using electronic health record data
Acute heart failure with mildly reduced ejection fraction and myocardial infarction: a multi-institutional cohort study
Characteristics associated with ventricular tachyarrhythmias and their prognostic impact in heart failure with mildly reduced ejection fraction
Transthyretin amyloidosis prevalence and characteristics in Korean patients with heart failure with preserved or mildly reduced ejection fractions
Real-world comparative effectiveness of ARNI versus ACEi/ARB in HF with reduced or mildly reduced ejection fraction
Predictors of mortality in heart failure patients with reduced or mildly reduced Ejection Fraction: The CASABLANCA HF Study
Association between class of foundational medication for heart failure and prognosis in heart failure with reduced/mildly reduced ejection fraction
Healthcare resource utilization and costs among patients with heart failure with preserved, mildly reduced, and reduced ejection fraction in Spain
Guideline-directed medical therapy is similarly effective in heart failure with mildly reduced ejection fraction
Semaglutide in patients with obesity and heart failure across mildly reduced or preserved ejection fraction
Guideline-directed medical therapy is similarly effective in heart failure with mildly reduced ejection fraction
Prognostic impact of prior LVEF in patients with heart failure with mildly reduced ejection fraction
Phenogrouping heart failure with preserved or mildly reduced ejection fraction using electronic health record data
Acute heart failure with mildly reduced ejection fraction and myocardial infarction: a multi-institutional cohort study
Characteristics associated with ventricular tachyarrhythmias and their prognostic impact in heart failure with mildly reduced ejection fraction
Transthyretin amyloidosis prevalence and characteristics in Korean patients with heart failure with preserved or mildly reduced ejection fractions
Real-world comparative effectiveness of ARNI versus ACEi/ARB in HF with reduced or mildly reduced ejection fraction
Predictors of mortality in heart failure patients with reduced or mildly reduced Ejection Fraction: The CASABLANCA HF Study
Association between class of foundational medication for heart failure and prognosis in heart failure with reduced/mildly reduced ejection fraction
Healthcare resource utilization and costs among patients with heart failure with preserved, mildly reduced, and reduced ejection fraction in Spain
Guideline-directed medical therapy is similarly effective in heart failure with mildly reduced ejection fraction
Semaglutide in patients with obesity and heart failure across mildly reduced or preserved ejection fraction
Guideline-directed medical therapy is similarly effective in heart failure with mildly reduced ejection fraction
Prognostic impact of prior LVEF in patients with heart failure with mildly reduced ejection fraction
Phenogrouping heart failure with preserved or mildly reduced ejection fraction using electronic health record data
Acute heart failure with mildly reduced ejection fraction and myocardial infarction: a multi-institutional cohort study
Characteristics associated with ventricular tachyarrhythmias and their prognostic impact in heart failure with mildly reduced ejection fraction